Encrypted | Login

All 2022 IMRT presentations

View another way?

MO-A-Virtual Acknowledging our Past & Moving IMRT QA Forward: Let's Do This Together
Acknowledging our Past & Moving IMRT QA Forward: Let's Do This Together
Presented by Jean Moran, PhD
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 16347


MO-A-Virtual Acknowledging our Past & Moving IMRT QA Forward: Let's Do This Together Q & A
Q & A
Presented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16348


MO-C-Virtual Gaps Filled: Advances in IMRT QA Guidance
Guidance for computational and systematic error prevention methods
Presented by Sonja Dieterich, PhD, UC Davis Medical Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16349


MO-C-Virtual Gaps Filled: Advances in IMRT QA Guidance
Guidance for Measurement-based Methods
Presented by Moyed Miften, PhD, University of Colorado School of Medicine
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16350


MO-C-Virtual Gaps Filled: Advances in IMRT QA Guidance Q & A
Q & A
Presented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16351


MO-E-Virtual Lessons learned from Pre-treatment IMRT QA Failures
Gems from the IROC-Houston Phantom Program
Presented by Andrea Molineu, MS, UT MD Anderson Cancer Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16352


MO-E-Virtual Lessons learned from Pre-treatment IMRT QA Failures
The Imperfection of our Analytical Methods for IMRT QA
Presented by Jennifer Steers, BSE, UC-San Diego
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16353


MO-E-Virtual Lessons learned from Pre-treatment IMRT QA Failures Q & A
Q & A
Presented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16354


MO-G-Virtual The Impact on IMRT QA of the Changing Landscape of Resource Utilization
A Holistic Approach Towards Resource Utilization
Presented by Per Halvorsen, MS, Beth Israel - Lahey Health
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16355


MO-G-Virtual The Impact on IMRT QA of the Changing Landscape of Resource Utilization
The impact of current and future IMRT Plan verification methods on reimbursement
Presented by Gerald White, MS, Medical Physics Services
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16356


MO-G-Virtual The Impact on IMRT QA of the Changing Landscape of Resource Utilization Q & A
Q & A
Presented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16357


MO-I-Virtual Where are our IMRT QA pain points? Discussion of Day 1 session
Panel Member
Presented by Jean Moran, PhD
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16358


MO-I-Virtual Where are our IMRT QA pain points? Discussion of Day 1 session
Panel Member
Presented by Sonja Dieterich, PhD, UC Davis Medical Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16359


MO-I-Virtual Where are our IMRT QA pain points? Discussion of Day 1 session
Panel Member
Presented by Moyed Miften, PhD, University of Colorado School of Medicine
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16360


MO-I-Virtual Where are our IMRT QA pain points? Discussion of Day 1 session
Panel Member
Presented by Andrea Molineu, MS, UT MD Anderson Cancer Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16361


MO-I-Virtual Where are our IMRT QA pain points? Discussion of Day 1 session
Panel Member
Presented by Jennifer Steers, BSE, UC-San Diego
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16362


MO-I-Virtual Where are our IMRT QA pain points? Discussion of Day 1 session
Panel Member
Presented by Per Halvorsen, MS, Beth Israel - Lahey Health
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16363


MO-I-Virtual Where are our IMRT QA pain points? Discussion of Day 1 session
Panel Member
Presented by Gerald White, MS, Medical Physics Services
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16364


MO-I-Virtual Where are our IMRT QA pain points? Discussion of Day 1 session Q & A
Q & A
Presented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16365


TU-A-Virtual Risk points in the Process of Care
IMRT QA: What it detects, what it doesn't
Presented by Koren Smith, MS, UMass Chan Medical School/IROC RI
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16374


TU-A-Virtual Risk points in the Process of Care
Building a better safety net: Combining QA approaches to maximize safety
Presented by Eric Ford, PhD, University of Washington
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16375


TU-A-Virtual Risk points in the Process of Care Q & A
Q & A
Presented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16376


TU-C-Virtual Delivery-based methods - Methodology and gaps
Delivery-based computational and transmission methods for IMRT QA
Presented by Justus Adamson, PhD, Duke University Medical Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16379


TU-C-Virtual Delivery-based methods - Methodology and gaps
Transit Dosimetry for IMRT QA
Presented by Peter Greer, PhD, Calvary Mater Newcastle
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16380


TU-C-Virtual Delivery-based methods - Methodology and gaps Q & A
Q & A
Presented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16381


TU-E-Virtual Emerging Computational Methods (AI) - Methodology, gaps, and promises for the future
Opportunities and cautions to advance IMRT QA with AI
Presented by Dan Ruan, PhD, UCLA School of Medicine
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16404


TU-E-Virtual Emerging Computational Methods (AI) - Methodology, gaps, and promises for the future
Finding the right fit for AI in IMRT QA
Presented by Alon Witztum, MS, University of California, San Francisco
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16405


TU-E-Virtual Emerging Computational Methods (AI) - Methodology, gaps, and promises for the future Q & A
Q & A
Presented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16406


TU-G-Virtual Designing a Comprehensive
Safety Barriers for IMRT Delivery Accuracy
Presented by Angelica Perez-Andujar, PhD, Memorial Sloan Kettering
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16386


TU-G-Virtual Designing a Comprehensive
Safety Barriers for IMRT Plan Quality
Presented by Kelly Paradis, PhD, Michigan Medicine
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16387


TU-G-Virtual Designing a Comprehensive
The Power of Automation for IMRT QA
Presented by Elizabeth Covington, PhD, University of Alabama-Birmingham
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16388


TU-G-Virtual Designing a Comprehensive
Putting the Pieces together to Increase Patient Safety
Presented by Jennifer O'Daniel, PhD, Duke University Medical Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16389


TU-G-Virtual Designing a Comprehensive Q & A
Q & A
Presented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16390


TU-I-Virtual The Way Forward - Focus on Day 2
Panel Member
Presented by Eric Ford, PhD, University of Washington
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16393


TU-I-Virtual The Way Forward - Focus on Day 2
Panel Member
Presented by Koren Smith, MS, UMass Chan Medical School/IROC RI
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16394


TU-I-Virtual The Way Forward - Focus on Day 2
Panel Member
Presented by Justus Adamson, PhD, Duke University Medical Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16395


TU-I-Virtual The Way Forward - Focus on Day 2
Panel Member
Presented by Peter Greer, PhD, Calvary Mater Newcastle
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16396


TU-I-Virtual The Way Forward - Focus on Day 2
Panel Member
Presented by Dan Ruan, PhD, UCLA School of Medicine
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16397


TU-I-Virtual The Way Forward - Focus on Day 2
Panel Member
Presented by Alon Witztum, MS, University of California, San Francisco
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16398


TU-I-Virtual The Way Forward - Focus on Day 2
Panel Member
Presented by Jennifer O'Daniel, PhD, Duke University Medical Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16399


TU-I-Virtual The Way Forward - Focus on Day 2
Panel Member
Presented by Kelly Paradis, PhD, Michigan Medicine
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16400


TU-I-Virtual The Way Forward - Focus on Day 2
Panel Member
Presented by Elizabeth Covington, PhD, University of Alabama-Birmingham
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16401


TU-I-Virtual The Way Forward - Focus on Day 2
Panel Member
Presented by Angelica Perez-Andujar, PhD, Memorial Sloan Kettering
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16402


TU-I-Virtual The Way Forward - Focus on Day 2 Q & A
Q & A
Presented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16403